Accès gratuit
Numéro
Med Sci (Paris)
Volume 22, Numéro 5, Mai 2006
Page(s) 519 - 524
Section M/S revues
DOI https://doi.org/10.1051/medsci/2006225519
Publié en ligne 15 mai 2006
  1. Duro D, Bernard O, Della Valle V, et al. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 1995; 11 : 21–9.
  2. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83 : 993–1000.
  3. Della Valle V, Duro D, Bernard O, Larsen CJ. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene. Oncogene 1997; 15 : 2475–81.
  4. Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 1998; 92 : 713–23.
  5. Llanos S, Clark PA, Rowe J, Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 2001; 3 : 445–52.
  6. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000; 2 : 148–55.
  7. Weber JD, Jeffers JR, Rehg JE, et al. p53-independent functions of the p19ARF tumor suppressor gene. Genes Dev 2000; 14 : 2358–65.
  8. Eymin B, Karayan L, Seite P, et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 20 : 1033–41.
  9. Hannan KM, Hannan RD, Rothblum LI. Transcription by polymerase I. Front Biosci 1998; 3 : 376–98
  10. Russell J, Zomerdijk JC. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem Sci 2005; 30 : 87–96.
  11. Voit R, Kuhn A, Sander EE, Grummt I. Activation of mammalian ribosomal gene transcription requires phosphorylation of the nucleolar transcription factor UBF. Nucleic Acids Res 1995; 23 : 2593–9.
  12. Grummt I. Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Prog Nucleic Acid Res Mol Biol 1999; 62 : 109–54.
  13. Moss T, Stefanovsky VY. At the center of eukaryotic life. Cell 2002; 109 : 545–8.
  14. Karayan L, Riou JF, Seite P, et al. Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene 2001; 20 : 836–48.
  15. Ayrault O, Karayan L, Riou JF, et al. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I. Oncogene 2003; 22 : 1945–54.
  16. Ayrault O, Andrique L, Larsen CJ, Seite P. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes. Oncogene 2004; 23 : 8097–104.
  17. Eymin B, Leduc C, Coll JL, et al. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003; 22 : 1822–35.
  18. Pourquier P, Kohlhagen G, Urasaki Y. Induction of topoisomerase I cleavage complexes by staurosporine in apoptotic leukaemia cells : could topoisomerase I act as an apoptotic endonuclease ? Proc Am Assoc Cancer Res 2001; 42 : 303.
  19. Voit R, Schnapp A, Kuhn A, et al. The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C terminal hyperacidic tail which is essential for transactivation. EMBO J 1992; 11 : 2211–8.
  20. Voit R, Hoffmann M, Grummt I. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J 1999; 18 : 1891–9.
  21. Stefanovsky VY, Pelletier G, Hannan R, et al. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol Cell 2001; 8 : 1063–73.
  22. Klein J, Grummt I. Cell cycle-dependent regulation of RNA polymerase I transcription : the nucleolar transcription factor UBF is inactive in mitosis and early G1. Proc Natl Acad Sci USA 1999; 96 : 6096–101.
  23. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003; 11 : 415–24.
  24. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24 : 985–96.
  25. Itahana K, Bhat KP, Jin A, et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003; 12 : 1151–64.
  26. Andrique L, Ayrault O, Larsen CJ, Séité P. In vitro and in vivo analysis of the interaction between 5,8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF. Oncogene 2005; 24 : 2580–4.
  27. Zhang Y, Xiong Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ 2001; 12 : 175–86.
  28. Piazza F, Gurrieri C, Pandolfi PP. The theory of APL. Oncogene 2001; 20 : 7216–22.
  29. Duyster J, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 2001; 20 : 5623–37.
  30. Falini B, mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352 : 254–66.
  31. Grisendi S, Pandolfi PP. NPM mutations in acute myelogenous leukemia. N Engl J Med 2005; 352 : 291–2.
  32. Den Besten V, Kuo ML, Williams RT, Sherr CJ. Myeloid leukaemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. Cell Cycle 2005; 4 : 1593–8.
  33. Tago K, Chiocca S, Sherr CJ. Sumoylation induced by the Arf tumor suppressor : a p53-independent function. Proc Natl Acad Sci USA 2005; 102 : 7689–94.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.